Document:AXA/2025/FY/Earnings release: Difference between revisions

Content deleted Content added
doc_archive: publish chq99br5nr (original transcript) (.md link)
doc_archive: rerender chq99br5nr (renderer update)
Line 10:
| pages = 20
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/aZ_Ib8FoBIGEg123_AXA_PR_20260226.pdf
| stored_file = File:AXA-2025-FY-Earnings release.pdf
| wide = yes
| original_md = File:AXA<!-2025-FY ARCHIVE_MD_LINK_HERE -Earnings_release-original.md>
| docling_file = File:AXA<!-2025-FY ARCHIVE_DOCLING_LINK_HERE -Earnings_release-docling.txt>
| article = AXA/2025/FY/Earnings release
| doc_id = chq99br5nr
Line 136 ⟶ 137:
 
<div style="overflow-x:auto">
{| id="t3" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change on a reported basis
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | Solvency II ratio (%) {{fn ref|5|2=The Solvency II ratio is estimated primarily using AXA's internal model calibrated based on an adverse 1/200 years shock. For further information on AXA's internal model and Solvency II disclosures, please refer to AXA Group's Solvency and Financial Condition Report (SFCR) as of December 31, 2024, available on AXA's website (www.axa.com). The Solvency II ratio as of December 31, 2025 is adjusted to give effect to the full up to Euro 1.25 billion annual share buyback program and proposed Euro 2.32 per share dividend announced today.}}
Line 436 ⟶ 437:
! style="text-align:left" |
! style="text-align:right" |
! colspan="3" style="text-align:centerleft" | Insurer financial strength ratings
! colspan="2" style="text-align:centerleft" | AXA's credit ratings {{fn ref|22|2=AXA maintains up-to-date ratings information on its website at: https://www.axa.com/en/investor/financial-strength-ratings.}}
|-
! style="text-align:left" | Agency
Line 517 ⟶ 518:
|-
! style="text-align:left" | For 1 Euro
! colspan="2" style="text-align:centerleft" | End of Period Exchange rate
! colspan="2" style="text-align:centerleft" | Average Exchange rate
|-
! style="text-align:left" |
Line 624 ⟶ 625:
|-
! style="text-align:left" |
! colspan="4" style="text-align:centerleft" | Gross Written Premiums and Other Revenues
! colspan="2" style="text-align:centerleft" | o/w Property &amp; Casualty
! colspan="2" style="text-align:centerleft" | o/w Life &amp; Health
! colspan="2" style="text-align:centerleft" | o/w Asset Management
|-
! style="text-align:left" | In EUR million
Line 736 ⟶ 737:
|-
! style="text-align:left" |
! colspan="3" style="text-align:centerleft" | Underlying earnings
! colspan="2" style="text-align:centerleft" | o/w Property &amp; Casualty
! colspan="2" style="text-align:centerleft" | o/w Life &amp; Health
! colspan="2" style="text-align:centerleft" | o/w Asset Management
|-
! style="text-align:left" | In EUR million
Line 840 ⟶ 841:
|-
! style="text-align:left" |
! colspan="2" style="text-align:centerleft" | Commercial lines
! colspan="4" style="text-align:centerleft" | Personal lines
! colspan="4" style="text-align:centerleft" | AXA XL Reinsurance
! colspan="2" style="text-align:centerleft" | Total P&amp;C
|-
! style="text-align:left" | In EUR million
Line 1,077 ⟶ 1,078:
|-
! style="text-align:left" | Gross written premiums &amp; other revenues
! colspan="2" style="text-align:centerleft" | Total
! colspan="2" style="text-align:centerleft" | o/w Protection
! colspan="2" style="text-align:centerleft" | o/w G/A Savings
! colspan="2" style="text-align:centerleft" | o/w Unit-Linked
! colspan="2" style="text-align:centerleft" | o/w Health
|-
! style="text-align:left" | In EUR million
Line 1,190 ⟶ 1,191:
{| id="t16" class="wikitable fintable"
|-
! colspan="7" style="text-align:centerleft" | Life New Business Metrics FY25
! colspan="6" style="text-align:centerleft" | Health{{fn ref|i|2=Includes Health business written predominantly in Life entities}} New Business Metrics FY25
! colspan="6" style="text-align:centerleft" | Total{{fn ref|ii|2=Changes are at comparable basis (constant forex, scope and methodology)}} New Business Metrics FY25
|-
! style="text-align:left" | in Euro million
Line 1,299 ⟶ 1,300:
{| id="t17" class="wikitable fintable"
|-
! colspan="4" style="text-align:centerleft" | NB CSM to NBV
|-
! style="text-align:left" | in Euro million